From Bench to the Clinic: The Path to Translation of Nanotechnology?Enabled mRNA SARS?CoV?2 Vaccines

• 作者: Diana O.Lopez?Cantu Xichi Wang Hector Carrasco?Magallanes Samson Afewerki Xingcai Zhang Joseph V.Bonventre Guillermo U.Ruiz?Esparza
• 来源期刊: 纳微快报（英文版）
• 年，卷（期）: 2022,（3）
• 页码范围: 1-31
• 页数: 31页
• 语种: 英文

摘要

During the last decades, the use of nanotechnology in med icine has effectively been translated to the design of drug delivery sys?tems, nanostructured tissues, diagnostic platforms, and novel nano?materials against several human diseases and infectious pathogens. Nanotechnology-enabled vaccines have been positioned as solutions to mitigate the pandemic outbreak caused by the novel pathogen severe acute respiratory syndrome coronavirus 2. To fast-track the develop?ment of vaccines, unprecedented industrial and academic collabora?tions emerged around the world, resulting in the clinical translation of effective vaccines in less than one year. In this article, we provide an overview of the path to translation from the bench to the clinic of nanotechnology-enabled messenger ribonucleic acid vaccines and examine in detail the types of delivery systems used, their mechanismsof action, obtained results during each phase of their clinical development and their regulatory approval process. We also analyze how nanotechnology is impacting global health and economy during the COVID-19 pandemic and beyond.